Who is sponsoring NCT00751933?

NCT00751933 is sponsored by Haukeland University Hospital.

What condition does NCT00751933 study?

NCT00751933 studies Ulcerative Colitis.

What drugs are being tested in NCT00751933?

Interventions: Vaccine Vivotif + Vaccine Dukoral + oats, Vaccine Vivotif + Vaccine Dukoral, Oats, Placebo.

What is the status of NCT00751933?

NCT00751933 is currently TERMINATED.

Last reviewed 2015-04-10 · How we verify

A Controlled Study of Salmonella Ty21a and Cholera/ ETEC-vaccine and the Role of Oats in Daily Diet as a New Treatment in Patients With Mild or Moderate Ulcerative Colitis.

NCT00751933 Phase 2 TERMINATED Results posted

Ulcerative colitis is a chronic inflammatory bowel disease caused by an imbalance between natural defence mechanisms in the intestinal mucosa and microbes in the intestinal lumen. We hypothesise that an improvement or even normalisation of this balance may be achieved by the use of vaccines and dietary oats. The combined use of oral typhoid vaccine and cholera/ETEC-vaccine is supposed to stimulate mucosal defence factors, while dietary oats modifies the microbial environment inside the intestinal lumen. Or study aim is to show if such treatment brings symptom relief to patients with ulcerative colitis.

Details

Lead sponsor	Haukeland University Hospital
Phase	Phase 2
Status	TERMINATED
Enrolment	3
Start date	2008-10
Completion	2010-06

Conditions

Ulcerative Colitis

Interventions

Vaccine Vivotif + Vaccine Dukoral + oats
Vaccine Vivotif + Vaccine Dukoral
Oats
Placebo

Primary outcomes

Symptom Score Improvement of 3 or More During or After 6 Months — 6 months
No patient completed the study, therefore we have no information to report.

Countries

Norway